Centre Hospitalier De Troyes — Clinical Trial Site

13 Registered trials

7 Currently recruiting

Organisation

Centre Hospitalier De Troyes

Location

Troyes Cedex, France

Identifier

ORG-100049906

Address

101 Avenue Anatole France, Cs 20718, 10003, France

Departments

Département d’Hématologie clinique
Hématologie
Hematology Department
Médecine gériatrique
Médecine Interne – Maladies Infectieuses
Néonatologie et réanimation néonatale
Neonatology
oncology
Recherche Clinique
Service Cardiologie - Soins intensifs
Service Hématologie
Unité d'hématologie clinique

Clinical trials at this site (13)

Search interface

Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial Pending

2024-510811-32-00 acute pneumonia 5
GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Tran… Recruiting

2024-511437-35-00 Patients aged 18-65 years old with newly diagnosed prev 10 2026-01-05
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Umbilical vein catheterization through Wharton’s jelly in the delivery room : CaDOm multicenter clinical trial. Recruiting

2024-515249-41-00 Cardiorespiratory arrest at birth in full-term newborns 10 2025-10-01
Free regimen of Dexamethasone as initial therapy for advanced relapsed/refractory multiple myeloma: an open-label randomized, non-inferiorit… Recruiting

2024-510981-18-00 Multiple Myeloma Multiple myeloma (MM) is a B cell mali 5 2024-12-12
FIRST LINE CHEMOTHERAPY FOR METASTATIC GASTRO ENTERO PANCREATIC NEUROENDOCRINE CARCINOMA Recruiting

2024-515300-39-00 METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE 4 2024-10-18
Phase 3 study to assess the efficacy and safety of Givinostat versus hydroxyurea in Polycythemia Vera patients Recruiting

2022-502276-23-00 JAK2V617F-positive high-risk Polycythemia Vera 5 2024-04-25
MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remis… Recruiting

2024-514156-33-00 Patients in remission for granulomatosis with polyangii 5 2019-08-20
ISASOCUT-IFM2022-05-Multicenter phase 2 study of subcutaneous isatuximab plus bortezomib, lenalidomide and dexamethasone in the treatment of… Ended

2024-517099-39-00 Newly diagnosed transplant ineligible multiple myeloma 4 2024-11-18
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Ended

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11
Respiratory effect of the LISA (Less Invasive surfactant administration) method with sedation by propofol versus absence of sedation: Double… Ended

2024-518836-36-00 Respiratory Distress Syndrome of preterm babies born < 5 2019-10-07
OPEN LABEL PHASE 2 STUDY ON THE EFFICACY AND TOLERANCE OF A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN A… Ended

2024-516048-24-00 CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR I 4 2019-06-19
A RANDOMIZED TRIAL TESTING EARLY VERSUS LATE ONSET OF EPO ALFA TREATMENT IN LOWER RISK MDS WITH NON RBC TRANSFUSION DEPENDENT ANEMIA AND WI… Ended

2024-515356-21-00 Adult subject (18 years of age older) with low or inter 5 2018-04-17